62
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Development of antidotes for sodium monofluoroacetate (1080)

, , &
Pages 72-76 | Published online: 29 Sep 2008

References

  • AKIRA, T., HENRY, D., BALDWIN, R. A. and WASTERLAIN, C. G. 1994, Nitric oxide participates in excitotoxin mechanisms induced by chemical hypo xia. Brain Research, 645, 285–290.
  • ANITRA-SCHULTZ, R., COETZER, J. A., KELLERMAN, T. S. and NAUDE, T. W. 1982, Observations on the clinical, cardiac and histopathological effects of fluoroacetate in sheep. Onderstepoot Journal of Veterinary Research, 49, 237–245.
  • BEHL, C., WIDMANN, M., TRAPP, T. and HOLSBOER, E 1995, 17-13-estradiol protects neurons from oxidative stress induced cell death in vitro. Biochemical and Biophysical Research Communications, 216(2), 473–482.
  • BONFOCO, E., KRAINC, D., ANKARCRONA, M., NICOTERA, P. and LIPTON, S. A. 1995, Apoptosis and necrosis: two district events induced, respectively, by mild and intense insults with NMDA or nitric oxide/superoxide in cortical cell cultures. Proceedings of the National Academy of Sciences, USA, 92,7162–7166.
  • CHENOWETH, M. B. 1949, Monofluoroacetic acid and related compounds. Pharmacological Reviews, 1, 383A–24.
  • Com, D. W. 1998, Glutamate neurotoxicity and diseases of the nervous system. Neuron, 1(8), 623–634. COOK, C. J., EASON, C. T. and DEVINE, C. D. Sodium monofluoroacetate (1080) produces different patterns of intoxication in rats and chickens. Research in Veterinary Science (submitted).
  • EASON, C. T., FRAMPTON, C. M., HENDERSON, R., THOMAS, M. D. and MORGAN, D. R. 1993, Sodium monofluoroacetate and alternative toxins for possum control. New Zealand Journal of Zoology, 20, 329–334.
  • EASON, C. T., GOONERATNE, R. and RAMMELL, C. G. 1994, A review of the toxicokinetics and toxicodynamics of sodium monofluoracetate in animals. In Proceedings of the Science Workshop on 1080, A. A. Seawright and C. T. Eason, eds, The Royal Society of New Zealand, Misc. Series No. 28, pp. 82–89. New Zealand.
  • FADDA, E. 1989, Differential effects of the calcium antagonists nimodipine and flunarazine on dopamine metabolisms in the rat brain. Journal of Neural Transmission, 75, 195–204.
  • GRILLI, M., Pizzi, M., MEMO, M. and SPANO, P. 1996, Neuroprotection by aspirin and sodium salicylate through blockade of NF-K13 activation. Science, 274, 1383–1385.
  • KANTHASAMY, A. G., BOROWITZ, J. L., PAVLAKOVIC, G. and Isom, G. E. 1994, Dopaminergic neurotoxicity of cyanide: neurochemical, histological and behavioural characterisation. Toxicology and Applied Pharmacology, 126, 156–163.
  • KIRSTEN, E., SHARMA, M. L. and KUN, E. 1978, Molecular toxicity of (—) erythro-fluorocitrate: selective inhibition of citrate transport in mitochondria and the binding of fluorocitrate to mitochondrial proteins. Molecular Pharmacology, 14, 172–184.
  • LIVINGSTONE, P G. 1994, The use of 1080 in New Zealand. In Proceedings of the Science Workshop on 1080, A. A. Seawright and C. T. Eason, eds, The Royal Society of New Zealand, Misc. Series No. 28, pp. 1–9. New Zealand.
  • OLNEY, J. 1990, Excitotoxin mediated neuron death in young and old age. Progress in Brain Research, 86, 37A–9.
  • OMARA, E and SISODIA, C. S. 1990, Evaluation of potential antidotes for sodium monofluoroacetate in mice. Veterinary and Human Toxicology, 32, 427–431.
  • RAMMELL, C. A., HOOGENBOOM, J. J. and JULIAN, A. E 1985, Treatment of 1080 poisoning in dogs with glycerol monoacetate. New Zealand Veterinary Journal, 33, 149–150.
  • SAPOLSKY, R., KREY, L. and McEVEN, B. 1986, The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocrine Reviews, 7, 284–301.
  • SAVARIE, P J. 1984, Toxic characterisation of fluorocitrate, the toxic metabolite of compound 1080. Proceedings of the 11th Vertebrate Pest Conference, pp. 132–137.
  • SCHWARTZ, L. M. and MILLIGAN, C. E. 1996, Cold thoughts of death: the role of ICE protease s in neuronal cell death. Trends in Neuroscience, 19(12), 555–562.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.